Medical Polymer Market

The medical polymer market is projected to reach USD 71.92 billion by 2031 from USD 48.27 billion in 2026, at a CAGR of 8.3% during the forecast period. The medical polymer sector is supported by an increase in demand for minimally invasive procedures, an increase in chronic disease, an aging population, and the demand for lighter, biocompatible, and organic materials and implants. High spending on health care will increase adoption of polymers in diagnostics, packaging, and wound care. The development of smart and stimuli responsive polymer continues to emerge with bioresorbable hydrogels, electroresponsive films for controlled drug delivery, and self-healing hydrogels for targeted therapies or tissue engineering. Plasma surface modification is improving the adhesion of cells and biocompatibility to implants/scaffolds. At the same time, 4D printing's ability to dynamically change the size and components of plant oil-based polymer scaffolds will enable dynamic/personalized biomedical devices. These factors are enabling more sustained growth, greater functionality, and a greater range of applications for medical polymers across the established global healthcare system.

The medical polymer market is dominated by key manufacturers such as BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese Corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others. These players have followed many product launches, deals, and expansions from January 2023 to August 2026 to expand their market share and geographical reach.

To know about the assumptions considered for the study download the pdf brochure

In May 2026, BASF launched a BPA-free food-contact material range within its Ultradur polybutylene terephthalate portfolio to ensure EU compliance. These high-performance polymers for food-contact applications are closely related to medical plastics, showcasing BASF's expertise in specialty polymer formulations.

BASF (Germany) is a global leader in the chemical industry with about 111,481 employees across six business segments: chemicals, materials, industrial solutions, surface technologies, nutrition & care, and agricultural solutions. The company does offer medical polymers under its materials division business segment. BASF's unique capabilities range from providing industries with a large range of chemicals to providing farmers with agricultural solutions. With over 390 sites worldwide, BASF offers various solutions for the healthcare industry, including applications for diagnostics, laboratory solutions, surgical instruments, prosthetics, and medical disposables. BASF SE has a significant sales presence in Asia Pacific, Europe, Latin America, North America, and the Middle East & Africa.

Saudi Basic Industries Corporation (SABIC) (Saudi Arabia) is one of the leading global producers of petrochemicals in the non-oil sector. It operates through three primary business units, namely Petrochemicals, Specialties, and Agri-Nutrients, and Hadeed. SABIC's products are used in construction, medical devices, packaging, transportation, clean energy, and many others. Within its Petrochemicals & Specialties business unit, SABIC provides medical polymers. It has 65 operational manufacturing/compounding sites across the world and sells in more than 100 countries in North America, South America, the Middle East & Africa, Asia Pacific, and Europe. The company has over 9,948 primary patents and pending patent applications, and 18 technology/innovation centers around the world.

Market Ranking

The medical polymer market is fragmented, with five main players collectively holding 20-25% of the total market share. BASF, SABIC, Covestro AG, Celanese Corporation, and Evonik Industries have a considerably high standing in the medical polymer market, backed by their large product portfolios, global presence, and ability to innovate. BASF is the highest achiever following many years of developing and expanding its portfolio of medical-grade polymers, consistently improving labs for research and development. SABIC offers high-performing polymers specifically designed for medical devices and packaging. Covestro AG is recognized around the world for its polycarbonates (specialty) and thermoplastic polyurethane and polycarbonate. Covestro's polymer materials have been recognized for their biocompatibility and durability. Celanese Corporation offers a variety of high-performance engineered polymers designed for surgical instruments and drug delivery systems. The actions of Celanese stem from a customer-focused commitment. Evonik industries continue to advance market opportunities in bioresorbable and specialty polymers used in implants and wound care.

Related Reports:

Medical Polymer Market by Type (Medical Plastics, Medical Elastomers), Application (Medical Disposables, Medical Instruments and Devices, Prosthetics, Diagnostics Instruments and Tools), Manufacturing Technology, and Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]